# A Phase II Study of Maintenance With Azacitidine in MDS Patients

> **NCT00446303** · PHASE2 · TERMINATED · sponsor: **Groupe Francophone des Myelodysplasies** · enrollment: 39 (actual)

## Conditions studied

- Leukemia, Myelocytic, Acute
- Myelodysplastic Syndromes

## Interventions

- **DRUG:** Azacitidine

## Key facts

- **NCT ID:** NCT00446303
- **Lead sponsor:** Groupe Francophone des Myelodysplasies
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-07
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2012-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00446303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00446303, "A Phase II Study of Maintenance With Azacitidine in MDS Patients". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00446303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*